Single Photon Emission Computed Tomography (SPECT) Experience with (S)-5-[123I]iodo-3-(2-azetidinylmethoxy)pyridine (5-[123I]IA) in the Living Human Brain of Smokers and Nonsmokers

JAMES ROBERT BRAŠIĆ1,*, YUN ZHOU1, JOHN L. MUSACHIO2, JOHN HILTON1, HONG FAN1, ANDREW CRABB1, CHRISTOPHER J. ENDRES1, MELVIN J. REINHARDT1, AHMET S. DOGAN1, MOHAB ALEXANDER1, OLIVIER ROUSSET1, MARIKA A. MARIS1, JEFFREY GALECKI1, AYON NANDI1, and DEAN F. WONG1 1 Division of Nuclear Medicine, Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287

[1]  Marianne Patt,et al.  In vivo measurement of nicotinic acetylcholine receptors with [18F]norchloro‐fluoro‐homoepibatidine , 2008, Synapse.

[2]  F. Jessen,et al.  Smoking upregulates α4β2* nicotinic acetylcholine receptors in the human brain , 2008, Neuroscience Letters.

[3]  E. Perry,et al.  The effects of donepezil on nicotinic receptor status in dementia: a 123I-5IA-85380 SPECT study , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[4]  U. Ackermann-Liebrich,et al.  Secondhand smoke and health-related quality of life in never smokers: results from the SAPALDIA cohort study 2. , 2007, Archives of internal medicine.

[5]  Marianne Patt,et al.  Synthesis procedure for routine production of 2-[18F]fluoro-3-(2(S)-azetidinylmethoxy)pyridine (2-[18F]F-A-85380). , 2007, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[6]  H. Fukuyama,et al.  Temporal Change in Human Nicotinic Acetylcholine Receptor After Smoking Cessation: 5IA SPECT Study , 2007, Journal of Nuclear Medicine.

[7]  J. Buccafusco,et al.  Profile of nicotinic acetylcholine receptor agonists ABT-594 and A-582941, with differential subtype selectivity, on delayed matching accuracy by young monkeys. , 2007, Biochemical pharmacology.

[8]  M. Filip,et al.  Effects of the serotonin 5-HT2A and 5-HT2C receptor ligands on the discriminative stimulus effects of nicotine in rats. , 2007, European journal of pharmacology.

[9]  E. Stein,et al.  NIDA522131, a new radioligand for imaging extrathalamic nicotinic acetylcholine receptors: in vitro and in vivo evaluation , 2007, Journal of neurochemistry.

[10]  H. Fukuyama,et al.  Quantification of nicotinic acetylcholine receptors in Parkinson's disease with 123I-5IA SPECT , 2007, Journal of the Neurological Sciences.

[11]  S Katharine Hammond,et al.  Secondhand smoke exposure, pulmonary function, and cardiovascular mortality. , 2007, Annals of epidemiology.

[12]  M. Krantz,et al.  Acute vs chronic secondhand smoke exposure. , 2007, Archives of internal medicine.

[13]  P. Brust,et al.  Measurement of the alpha4beta2* nicotinic acetylcholine receptor ligand 2-[(18)F]Fluoro-A-85380 and its metabolites in human blood during PET investigation: a methodological study. , 2007, Nuclear medicine and biology.

[14]  J. Seibyl,et al.  [123I]5‐IA‐85380 SPECT Imaging of β2‐Nicotinic Acetylcholine Receptor Availability in the Aging Human Brain , 2007, Annals of the New York Academy of Sciences.

[15]  S. Potkin,et al.  Effect of acetylcholinesterase inhibitors on the binding of nicotinic α4β2 receptor PET radiotracer, 18F‐nifene: A measure of acetylcholine competition , 2007, Synapse.

[16]  E. Perry,et al.  α4β2 nicotinic receptor status in Alzheimer’s disease using 123I-5IA-85380 single-photon-emission computed tomography , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[17]  P. Szekeres,et al.  Ligands selective for α4β2 but not α3β4 or α7 nicotinic receptors generalise to the nicotine discriminative stimulus in the rat , 2006, Psychopharmacology.

[18]  U. Winzer-Serhan,et al.  Chronic neonatal nicotine upregulates heteromeric nicotinic acetylcholine receptor binding without change in subunit mRNA expression , 2006, Brain Research.

[19]  J. Langston,et al.  Partial Recovery of Striatal Nicotinic Receptors in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-Lesioned Monkeys with Chronic Oral Nicotine , 2006, Journal of Pharmacology and Experimental Therapeutics.

[20]  Suchitra Krishnan-Sarin,et al.  Human Tobacco Smokers in Early Abstinence Have Higher Levels of β2* Nicotinic Acetylcholine Receptors than Nonsmokers , 2006, The Journal of Neuroscience.

[21]  Svetlana I. Chefer,et al.  Cigarette Smoking Saturates Brain α4β2 Nicotinic Acetylcholine Receptors , 2006 .

[22]  Angelo Bifone,et al.  Region-Specific Effects of Nicotine on Brain Activity: A Pharmacological MRI Study in the Drug-Naïve Rat , 2006, Neuropsychopharmacology.

[23]  A. Hufnagel,et al.  Alteration of the in vivo nicotinic receptor density in ADNFLE patients: a PET study. , 2006, Brain : a journal of neurology.

[24]  E. Sher,et al.  α4β2 Nicotinic Receptors with High and Low Acetylcholine Sensitivity: Pharmacology, Stoichiometry, and Sensitivity to Long-Term Exposure to Nicotine , 2006, Molecular Pharmacology.

[25]  M. Quik,et al.  Differential Regulation of Mesolimbic α3*/α6β2* and α4β2* Nicotinic Acetylcholine Receptor Sites and Function after Long-Term Oral Nicotine to Monkeys , 2006, Journal of Pharmacology and Experimental Therapeutics.

[26]  M. Filip,et al.  Evaluation of the role of nicotinic acetylcholine receptor subtypes and cannabinoid system in the discriminative stimulus effects of nicotine in rats. , 2006, European journal of pharmacology.

[27]  E. Sher,et al.  5-I A-85380 and TC-2559 differentially activate heterologously expressed α4β2 nicotinic receptors , 2006 .

[28]  E. Levin,et al.  Ventral hippocampal α7 and α4β2 nicotinic receptor blockade and clozapine effects on memory in female rats , 2006, Psychopharmacology.

[29]  J. Staley,et al.  Chemical fate of the nicotinic acetylcholinergic radiotracer [123I]5-IA-85380 in baboon brain and plasma. , 2006, Nuclear medicine and biology.

[30]  J. Kennedy,et al.  Genetic interaction between α4 and β2 subunits of high affinity nicotinic receptor: analysis in schizophrenia , 2006, Experimental Brain Research.

[31]  J. Steinbach,et al.  Autoradiography of 2‐[18F]F‐A‐85380 on nicotinic acetylcholine receptors in the porcine brain in vitro , 2006, Synapse.

[32]  Masanori Ichise,et al.  Widespread decrease of nicotinic acetylcholine receptors in Parkinson's disease , 2006, Annals of neurology.

[33]  M. Mandelkern,et al.  Whole-body radiation dosimetry of 2-[18F]Fluoro-A-85380 in human PET imaging studies. , 2005, Nuclear medicine and biology.

[34]  Ming-Wei Wang,et al.  A robust homogeneous binding assay for α4β2 nicotinic acetylcholine receptor , 2005, Acta Pharmacologica Sinica.

[35]  J. Seibyl,et al.  Nicotinic Acetylcholine Receptors in Human Brain by the Constant Infusion Paradigm: Feasibility and Reproducibility , 2005 .

[36]  Christopher C Rowe,et al.  Simplified quantification of nicotinic receptors with 2[18F]F-A-85380 PET. , 2005, Nuclear medicine and biology.

[37]  Jean-Dominique Gallezot,et al.  In vivo imaging of human cerebral nicotinic acetylcholine receptors with 2-18F-fluoro-A-85380 and PET. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[38]  S. Wonnacott,et al.  Functional responses and subunit composition of presynaptic nicotinic receptor subtypes explored using the novel agonist 5-iodo-A-85380 , 2004, Neuropharmacology.

[39]  Hidenao Fukuyama,et al.  Quantification of human nicotinic acetylcholine receptors with 123I-5IA SPECT. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[40]  D. Perry,et al.  Subtype-Selective Up-Regulation by Chronic Nicotine of High-Affinity Nicotinic Receptors in Rat Brain Demonstrated by Receptor Autoradiography , 2003, Journal of Pharmacology and Experimental Therapeutics.

[41]  C. M. Leung.  Neuropsychopharmacology: The Fifth Generation of Progress , 2003 .

[42]  Monique Ernst,et al.  2 [18F]F‐A85380: PET imaging of brain nicotinic acetylcholine receptors and whole body distribution in humans , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[43]  Marcel Ricard,et al.  Biodistribution and radiation dosimetry of 18F-fluoro-A-85380 in healthy volunteers. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[44]  R. Dannals,et al.  Pharmacological evaluation of a Br‐76 analog of epibatidine: A potent ligand for studying brain nicotinic acetylcholine receptors , 2002, Synapse.

[45]  J. Seibyl,et al.  Whole-body biodistribution, radiation absorbed dose, and brain SPET imaging with [123I]5-I-A-85380 in healthy human subjects , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[46]  Ruben Abagyan,et al.  Structural model of nicotinic acetylcholine receptor isotypes bound to acetylcholine and nicotine , 2002, BMC Structural Biology.

[47]  John L. Musachio,et al.  Human [/sup 123/I]5-I-A-85380 dynamic SPECT studies in normals: kinetic analysis and parametric imaging , 2001, 2001 IEEE Nuclear Science Symposium Conference Record (Cat. No.01CH37310).

[48]  Ferran Sanz,et al.  Neuronal nicotinic receptor agonists: a multi-approach development of the pharmacophore , 2001, J. Comput. Aided Mol. Des..

[49]  D. Bertrand,et al.  Neuronal nicotinic receptors: from structure to function. , 2001, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[50]  D. Bertrand,et al.  Chronic Exposure to Nicotine Upregulates the Human α4β2 Nicotinic Acetylcholine Receptor Function , 2001, The Journal of Neuroscience.

[51]  S R Meikle,et al.  In vivo imaging of nicotinic receptor upregulation following chronic (-)-nicotine treatment in baboon using SPECT. , 2001, Nuclear medicine and biology.

[52]  Y. Allen,et al.  Nicotine and its interaction with β-amyloid protein: a short review , 2001, Biological Psychiatry.

[53]  James Robert Brašić,et al.  In vivo imaging of neurotransmitter systems in neuropsychiatry , 2001, Clinical Neuroscience Research.

[54]  P. Sanberg,et al.  Comorbid bipolar disorder in Tourette’s syndrome responds to the nicotinic receptor antagonist mecamylamine (Inversine) , 2000, Biological Psychiatry.

[55]  A. C. Collins,et al.  Abnormal Regulation of High Affinity Nicotinic Receptors in Subjects with Schizophrenia , 2000, Neuropsychopharmacology.

[56]  J. Seibyl,et al.  Measurement of α4β2 nicotinic acetylcholine receptors with [123I]5-I-A-85380 SPECT , 2000 .

[57]  P. Riederer,et al.  Human post-mortem striatal α4β2 nicotinic acetylcholine receptor density in schizophrenia and Parkinson's syndrome , 2000, Neuroscience Letters.

[58]  J. Links,et al.  6-[18F]fluoro-A-85380, a novel radioligand for in vivo imaging of central nicotinic acetylcholine receptors. , 2000, Life sciences.

[59]  D. Wong,et al.  Column-switching HPLC for the analysis of plasma in PET imaging studies. , 2000, Nuclear medicine and biology.

[60]  Agneta Nordberg,et al.  Neuronal nicotinic receptors in the human brain , 2000, Progress in Neurobiology.

[61]  R. Drucker-Colín,et al.  Nicotine, brain nicotinic receptors, and neuropsychiatric disorders. , 2000, Archives of medical research.

[62]  P. Newhouse,et al.  Nicotinic systems in central nervous systems disease: degenerative disorders and beyond. , 2000, Pharmaceutica acta Helvetiae.

[63]  Robert B. Innis,et al.  5-Iodo-A-85380, an α4β2 Subtype-Selective Ligand for Nicotinic Acetylcholine Receptors , 2000 .

[64]  T. Slotkin,et al.  Adolescent nicotine exposure causes persistent upregulation of nicotinic cholinergic receptors in rat brain regions , 1999, Brain Research.

[65]  C Crouzel,et al.  Imaging central nicotinic acetylcholine receptors in baboons with [18F]fluoro-A-85380. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[66]  C. Stockmeier,et al.  Increased nicotinic receptors in brains from smokers: membrane binding and autoradiography studies. , 1999, The Journal of pharmacology and experimental therapeutics.

[67]  C Crouzel,et al.  Synthesis and nicotinic acetylcholine receptor in vivo binding properties of 2-fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine: a new positron emission tomography ligand for nicotinic receptors. , 1999, Journal of medicinal chemistry.

[68]  H. Shimizu,et al.  Development of a screening questionnaire for tobacco/nicotine dependence according to ICD-10, DSM-III-R, and DSM-IV. , 1999, Addictive behaviors.

[69]  Z. Elazar,et al.  Potentiation of haloperidol catalepsy by microinjections of nicotine into the striatum or pons in rats. , 1999, Life sciences.

[70]  D. Wong,et al.  Synthesis of an I-123 analog of A-85380 and preliminary SPECT imaging of nicotinic receptors in baboon. , 1999, Nuclear medicine and biology.

[71]  J M Links,et al.  In vivo imaging of brain nicotinic acetylcholine receptors with 5-[123I]iodo-A-85380 using single photon emission computed tomography. , 1998, Life sciences.

[72]  E. London,et al.  2-, 5-, and 6-Halo-3-(2(S)-azetidinylmethoxy)pyridines: synthesis, affinity for nicotinic acetylcholine receptors, and molecular modeling. , 1998, Journal of medicinal chemistry.

[73]  E. London,et al.  In vivo studies with [125I]5‐I‐A‐85380, a nicotinic acetylcholine receptor radioligand , 1998, Neuroreport.

[74]  E. Perry,et al.  Dopamine and nicotinic receptor binding and the levels of dopamine and homovanillic acid in human brain related to tobacco use , 1998, Neuroscience.

[75]  J. Changeux,et al.  Allosteric nicotinic receptors, human pathologies , 1998, Journal of Physiology-Paris.

[76]  C. Gotti,et al.  Human neuronal nicotinic receptors , 1997, Progress in Neurobiology.

[77]  A. C. Collins,et al.  Effect of Smoking History on [ 3 H]nicotine Binding in Human Postmortem Brain 1 , 2022 .

[78]  S. Dursun,et al.  Differential effects of transdermal nicotine on microstructured analyses of tics in Tourette's syndrome: an open study , 1997, Psychological Medicine.

[79]  A. Lammertsma,et al.  Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.

[80]  P. Sanberg,et al.  Case study: long-term potentiation of neuroleptics with transdermal nicotine in Tourette's syndrome. , 1996, Journal of the American Academy of Child and Adolescent Psychiatry.

[81]  J. Rabe-Jabłońska,et al.  [Affective disorders in the fourth edition of the classification of mental disorders prepared by the American Psychiatric Association -- diagnostic and statistical manual of mental disorders]. , 1993, Psychiatria polska.

[82]  S Wonnacott,et al.  The paradox of nicotinic acetylcholine receptor upregulation by nicotine. , 1990, Trends in pharmacological sciences.

[83]  M. Benwell,et al.  Evidence that Tobacco Smoking Increases the Density of (−)‐[3H]Nicotine Binding Sites in Human Brain , 1988, Journal of neurochemistry.

[84]  N. Benowitz,et al.  Improved gas chromatographic method for the determination of nicotine and cotinine in biologic fluids. , 1981, Journal of chromatography.

[85]  D. Groggel.  Practical Nonparametric Statistics , 1972, Technometrics.

[86]  J. Overall,et al.  The Brief Psychiatric Rating Scale , 1962 .

[87]  J. Vincent,et al.  Association of alpha4beta2 nicotinic receptor and heavy smoking in schizophrenia. , 2007, Journal of psychiatry & neuroscience : JPN.

[88]  E. Tüzün.  Neuronal acetylcholine receptor alpha9-subunit: a possible central nervous system autoantigen. , 2006, Medical hypotheses.

[89]  James Robert Brašić.  Treatment of movement disorders in autism spectrum disorders , 2003 .

[90]  Dean F. Wong,et al.  Positron emission tomography--a tool for identifying the effects of alcohol dependence on the brain. , 2003 .

[91]  James Robert Brašić,et al.  PROOF OF CONCEPT: FUNCTIONAL MODELS FOR DRUG DEVELOPMENT IN HUMANS , 2002 .

[92]  J. Seibyl,et al.  Measurement of plasma metabolites of (S)-5-[123I]iodo-3-(2-azetidinylmethoxy)pyridine (5-IA-85380), a nicotinic acetylcholine receptor imaging agent, in nonhuman primates. , 2001, Nuclear medicine and biology.

[93]  J. Fowler,et al.  Synthesis and evaluation of 6-[(18)F]fluoro-3-(2(S)-azetidinylmethoxy)pyridine as a PET tracer for nicotinic acetylcholine receptors. , 2000, Nuclear medicine and biology.

[94]  J. Gault,et al.  Nicotinic receptors, smoking and schizophrenia. , 1998, Restorative neurology and neuroscience.

[95]  P. Sanberg,et al.  Nicotine for the treatment of Tourette's syndrome. , 1997, Pharmacology & therapeutics.

[96]  S. Dursun,et al.  The efficacy of a dose-escalated application of transdermal nicotine plus sulpiride in Tourette’s syndrome , 1996, European Psychiatry.

[97]  K. Fagerström,et al.  Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders. , 1996, Pharmacology & therapeutics.

[98]  D. V. Jeste,et al.  Tardive dyskinesia. , 1993, Schizophrenia bulletin.

[99]  M. Denckla,et al.  Revised Neurological Examination for Subtle Signs (1985). , 1985, Psychopharmacology bulletin.

[100]  R. Rosenthal.  Meta-analytic procedures for social research , 1984 .